Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma

American Journal of Pathology

Volumn 164, Issue 6, 2004, Pages 2259-2267

  Rassidakis, George Z ^a   Lai, Raymond ^a   Herling, Marco ^a,b   Cromwell, Candy ^a   Schmitt Graeff, Annette ^b   Medeiros, L Jeffrey ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; RETINOBLASTOMA PROTEIN;

ALLELE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CHROMOSOME 13Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; NICK END LABELING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 2442659243     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63782-0     Document Type: Article

References (45)

1. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY: Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987, 235:1394-1399
2. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WF: Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987, 236:1657-1661
3. Knudson Jr AG: Retinoblastoma: a prototypic hereditary neoplasm. Semin Oncol 1978, 5:57-60
4. Classon M, Harlow E: The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002, 2:910-917
5. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A: A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 1992, 70:337-350
6. Kaelin Jr WG, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK: Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 1992, 70:351-364
7. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR: The E2F transcription factor is a cellular target for the RB protein. Cell 1991, 65:1053-1061
8. Johnson DG, Schwarz JK, Cress WD, Nevins JR: Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993, 365:349-352
9. Harbour JW, Dean DC: Corepressors and retinoblastoma protein function. Curr Top Microbiol Immunol 2001, 254:137-144
10. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677
11. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991, 67:293-302
12. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-1512
13. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994, 371:72-74
14. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH: p14ARF links the tumour suppressors RB and p53. Nature 1998, 395:124-125
15. Hsieh JK, Fredersdorf S, Kouzarides T, Martin K, Lu X: E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 1997, 11:1840-1852
16. Chau BN, Wang JY: Coordinated regulation of life and death by RB. Nat Rev Cancer 2003, 3:130-138
17. Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, Rasool O, Juliusson G, Gahrton G, Detlofsson R, Nikiforova N, Buys C, Soderhall S, Yankowsky N, Zabarovsky E, Einhorn S: 13q deletions in lymphoid malignancies. Blood 1995, 86:1911-1915
18. Hangaishi A, Ogawa S, Imamura N, Miyawaki S, Miura Y, Uike N, Shimazaki C, Emi N, Takeyama K, Hirosawa S, Kamada N, Kobayashi Y, Takemoto Y, Kitani T, Toyama K, Ohtake S, Yazaki Y, Ueda R, Hirai H: Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p161NK4A/CDKN2, MTS2/p151NK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 1996, 87:4949-4958
19. Galteland E, Smedshammer L, Suo Z, DeAngelis P, Stokke T: Proliferation-dependent expression and phosphorylation of pRB in B cell non-Hodgkin's lymphomas: dependence on RB1 copy number. Leukemia 2002, 16:1549-1555
20. Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofre C, Piris MA, Montserrat E, Cardesa A: Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Am J Pathol 1996, 148:1591-1600
21. Nguyen PL, Zukerberg LR, Benedict WF, Harris NL: Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma. Am J Clin Pathol 1996, 105:538-543
22. Geradts J, Andriko JW, Abbondanzo SL: Loss of tumor suppressor gene expression in high-grade but not low-grade non-Hodgkin's lymphomas. Am J Clin Pathol 1998, 109:669-674
23. Moller MB, Kania PW, Ino Y, Gerdes AM, Nielsen O, Louis DN, Skjodt K, Pedersen NT: Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p161NK4A. Leukemia 2000, 14:898-904
24. Bai M, Vlachonikolis J, Agnantis NJ, Tsanou E, Dimou S, Nicolaides C, Stefanaki S, Pavlidis N, Kanavaros P: Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Mod Pathol 2001, 14:1105-1113
25. Delsol G, Ralfkiaer E, Stein H, Wright D, Jaffe ES: Anaplastic large cell lymphoma. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Edited by ES Jafle, NL Harris, H Stein, JW Vardiman. Lyon, France, IARC Press, 2001, pp 230-235
26. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene ALK, to a nucleolar protein gene NPM, in non-Hodgkin's lymphoma. Science 1994, 263:1281-1284
27. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 1997, 14:2175-2188
28. Inghirami G, Macri L, Cesarman E, Chadburn A, Zhong J, Knowles DM: Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood 1994, 83:3581-3590
29. Chilosi M, Doglioni C, Magalini A, Inghirami G, Krampera M, Nadali G, Rahal D, Pedron S, Benedetti A, Scardoni M, Macri E, Lestani M, Menestrina F, Pizzolo G, Scarpa A: p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function. Blood 1996, 88:4012-4020
30. Chilosi M, Doglioni C, Yan Z, Lestani M, Menestrina F, Sorio C, Benedetti A, Vinante F, Pizzolo G, Inghirami G: Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol 1998, 152:209-217
31. Rassidakis GZ, Claret FX, Lai R, Zhang Q, Sarris AH, McDonnell TJ, Medeiros LJ: Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin Cancer Res 2003, 9:1121-1128
32. Rassidakis GZ, Sarris AH, Herling M, Ford RJ, Cabanillas F, McDonnell TJ, Medeiros LJ: Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage. Am J Pathol 2001, 159:527-535
33. Rassidakis GZ, Jones D, Thomaides A, Sen F, Lai R, Cabanillas F, McDonnell TJ, Medeiros LJ: Apoptotic rate in peripheral T-cell lymphomas: a study using a tissue microarray with validation on full tissue sections. Am J Clin Pathol 2002, 118:328-334
34. Katz RL, Caraway NP, Gu J, Jiang F, Pasco-Miller LA, Glassman AB, Luthra R, Hayes KJ, Romaguera JE, Cabanillas FF, Medeiros LJ: Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma. Am J Clin Pathol 2000, 114:248-257
35. Jiang F, Lin F, Price R, Gu J, Medeiros LJ, Zhang HZ, Xie SS, Caraway NP, Katz RL: Rapid detection of IgH/BCL2 rearrangement in follicular lymphoma by interphase fluorescence in situ hybridization with bacterial artificial chromosome probes. J Mol Diagn 2002, 4:144-149
36. Vega F, Medeiros LJ, Jones D, Abruzzo LV, Lai R, Manning J, Dunmire V, Luthra R: A novel four-color PCR assay to assess T-cell receptor gamma gene rearrangements in lymphoproliferative lesions. Am J Clin Pathol 2001, 116:17-24
37. Martinez JC, Piris MA, Sanchez-Beato M, Villuendas R, Orradre JL, Algara P, Sanchez-Verde L, Martinez P: Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction. J Pathol 1993, 169:405-412
38. Weide R, Tiemann M, Pfluger KH, Koppler H, Parvizi B, Wacker HH, Kreipe HH, Havemann K, Parwaresch MR: Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia 1994, 8:97-101
39. Wada M, Okamura T, Okada M, Teramura M, Masuda M, Motoji T, Mizoguchi H: Frequent chromosome arm 13q deletion in aggressive non-Hodgkin's lymphoma. Leukemia 1999, 13:792-798
40. Rosenwald A, Ott G, Krumdiek AK, Dreyling MH, Katzenberger T, Kalla J, Roth S, Ott MM, Muller-Hermelink HK: A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral T-cell lymphomas? Genes Chromosom Cancer 1999, 26:210-214
41. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P: Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000, 343:1910-1916
42. Levi E, Pfeifer WM, Kadin ME: CD30-activation-mediated growth inhibition of anaplastic large-cell lymphoma cell lines: apoptosis or cell-cycle arrest? Blood 2001, 98:1630-1632
43. Park MS, Rosai J, Nguyen HT, Capodieci P, Cordon-Cardo C, Koff A: p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc Natl Acad Sci USA 1999, 96:6382-6387
44. Takemura M, Ohoka F, Perpelescu M, Ogawa M, Matsushita H, Takaba T, Akiyama T, Umekawa H, Furuichi Y, Cook PR, Yoshida S: Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23. Exp Cell Res 2002, 276:233-241
45. Borer RA, Lehner CF, Eppenberger HM, Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989, 56:379-390